1. Home
  2. GEVO vs MHN Comparison

GEVO vs MHN Comparison

Compare GEVO & MHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEVO
  • MHN
  • Stock Information
  • Founded
  • GEVO 2005
  • MHN 1997
  • Country
  • GEVO United States
  • MHN United States
  • Employees
  • GEVO N/A
  • MHN N/A
  • Industry
  • GEVO Major Chemicals
  • MHN Investment Bankers/Brokers/Service
  • Sector
  • GEVO Industrials
  • MHN Finance
  • Exchange
  • GEVO Nasdaq
  • MHN Nasdaq
  • Market Cap
  • GEVO 285.1M
  • MHN N/A
  • IPO Year
  • GEVO 2011
  • MHN N/A
  • Fundamental
  • Price
  • GEVO $1.14
  • MHN $10.02
  • Analyst Decision
  • GEVO Buy
  • MHN
  • Analyst Count
  • GEVO 2
  • MHN 0
  • Target Price
  • GEVO $7.58
  • MHN N/A
  • AVG Volume (30 Days)
  • GEVO 2.4M
  • MHN 59.2K
  • Earning Date
  • GEVO 05-13-2025
  • MHN 01-01-0001
  • Dividend Yield
  • GEVO N/A
  • MHN 4.17%
  • EPS Growth
  • GEVO N/A
  • MHN N/A
  • EPS
  • GEVO N/A
  • MHN N/A
  • Revenue
  • GEVO $16,915,000.00
  • MHN N/A
  • Revenue This Year
  • GEVO $617.82
  • MHN N/A
  • Revenue Next Year
  • GEVO $84.22
  • MHN N/A
  • P/E Ratio
  • GEVO N/A
  • MHN N/A
  • Revenue Growth
  • GEVO N/A
  • MHN N/A
  • 52 Week Low
  • GEVO $0.48
  • MHN $8.69
  • 52 Week High
  • GEVO $3.39
  • MHN $10.81
  • Technical
  • Relative Strength Index (RSI)
  • GEVO 49.70
  • MHN 53.46
  • Support Level
  • GEVO $1.00
  • MHN $9.95
  • Resistance Level
  • GEVO $1.14
  • MHN $10.09
  • Average True Range (ATR)
  • GEVO 0.08
  • MHN 0.11
  • MACD
  • GEVO 0.00
  • MHN 0.04
  • Stochastic Oscillator
  • GEVO 60.87
  • MHN 87.27

About GEVO Gevo Inc.

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.

Share on Social Networks: